Hongri Pharmaceutical: As of September 30, 2025, the total number of company shareholders is 96,308.

NightAirdropper · 2026-04-12T06:08:55+00:00

Hongri Pharmaceutical responded on the investor relations platform that the number of shareholders is 96,308 accounts, and reiterated the combination of prudent operation and market value management, indicating management's emphasis on shareholder returns and committing to transparent communication to protect shareholders' interests.

NightAirdropper

2026-04-12 06:08:55

Abstract generation in progress

Securities Star News, Hongri Pharmaceutical (300026) responded to investor concerns on the investor relations platform on April 7.

Investor: What is the latest number of shareholders for the company?

**Hongri Pharmaceutical Secretary: **Hello, according to the relevant regulations of the “Shenzhen Stock Exchange Growth Enterprise Market Stock Listing Rules,” to ensure all investors have equal access to the same information, the company will disclose the number of shareholders at the end of each period in the periodic reports of the first quarter, semi-annual, third quarter, and year. As of September 30, 2025, the total number of shareholders is 96,308. Thank you for your attention!

Investor: Many traditional Chinese medicine companies are conducting share buybacks and increasing holdings by executives. On one hand, they proactively reduce share capital and manage market value; on the other hand, they demonstrate the management team’s confidence in the company’s development, such as Guangyuyuan, Dong’e Ejiao, and others. As a state-owned enterprise, where does your board and management’s sense of responsibility lie? Are you just passing time and building resumes?

**Hongri Pharmaceutical Secretary: **Hello, as a state-controlled listed company, the company’s board and management always uphold a high sense of responsibility. Under the premise of strictly adhering to state asset supervision and compliance governance, we maintain steady operations and focus on our core business. The company attaches great importance to market value management and shareholder returns, carefully studying the applicability of relevant tools based on actual conditions. The company will continue to improve performance and maintain transparent communication to genuinely safeguard the long-term interests of all shareholders. Thank you for your attention and valuable suggestions.

The above content is compiled from publicly available information by Securities Star, generated by AI algorithm (Network Information Backup 310104345710301240019), and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.